MedPath

Insights on type 2 Diabetes mellitus management from Ethiopian perspective and evaluation of the impact of a pharmaceutical care on clinical outcome and medication adherence in type 2 Diabetes mellitus patients: A randomized controlled study.

Not Applicable
Conditions
Nutritional, Metabolic, Endocrine
Registration Number
PACTR202109562160747
Lead Sponsor
Wachemo University research and community vice president
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

If they were aged 18 years or older
Treated at WUNEMMCS Hospital and diagnosed with type 2 diabetes at least 6 months previously,
Took at least 1 prescribed medication for diabetes
Had regular visits for last 6 months with or without concomitant
Willingness to participate

Exclusion Criteria

If they were missing visits in the previous six months
Not willing to participate
Participated in DM educational programs in the last 3 months
Mentally incapable to participate
Other types of diabetes
Pregnancy
Comorbidity of cancer, organ failure, or other severe diseases
Unable to communicate and understand Amharic language

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath